
Berger Montague Probes ADMA Biologics Over Alleged Channel-Stuffing
Philadelphia-based law firm Berger Montague has launched an investigation into the board of directors at ADMA Biologics, questioning whether the company artificially inflated revenue figures. The inquiry centers on allegations of channel-stuffing, a practice involving the distribution of products beyond market demand to boost financial results for its flagship therapy, ASCENIV.


























